${session.getAttribute("locale")} 5 Acceptability of an internet cognitive behavioural therapy program for people with early-stage cancer and cancer survivors with depression and/or anxiety: thematic findings from focus groups Wed 27 Nov 2019 12:59:54 AEST ]]> iCanADAPT Early protocol: Randomised controlled trial (RCT) of clinician supervised transdiagnostic internet-delivered cognitive behaviour therapy (iCBT) for depression and/or anxiety in early stage cancer survivors -vs- treatment as usual 0.6, power of 80%, and alpha at.05), but 10% more will be recruited to account for attrition. A solitary or cumulative diagnosis(es) of Major Depressive Episode (current), Generalised Anxiety Disorder, Illness Anxiety Disorder, Panic Disorder, Agoraphobia, and/or Adjustment disorder will be determined using modules from the Anxiety Disorders Interview Schedule for DSM-5. Depression and anxiety levels with be measured via the total score of the Hospital Anxiety and Depression scale (HADS-T), the primary outcome measure. Secondary measures will include the Kessler 10 to measure general distress, the Fear of Cancer Recurrence Inventory (FCRI) to measure the specific fear of cancer recurrence and the Functional Assessment of Cancer Therapy, General Version 4 (FACT-G) for self-report of physical, social, emotional and functional well-being. iCBT participants will complete the measures before lessons 1 and 5, at post-treatment and at 3-month follow-up. The TAU group will complete similar measures at weeks 1, 8 and 16 of the waiting period. Program efficacy will be determined using intent-to-treat mixed models. Maintenance of gains will be assessed at 3-month follow-up. Mediation analyses using PROCESS will be used to examine the association between change in depressive and anxious symptoms over time and changes in FCRI and FACT-G QOL in separate analysis. Discussion: This is the first RCT looking at iCBT specifically for clinical depression and/or anxiety in a cancer population. Findings will help to direct the role of iCBT in streamlined psycho-social care pathways. Trial registration: Australian New Zealand Clinical Trials Registry: ACTRN12616000231448, registered 19 th February 2016 ( ). This trial protocol is in compliance with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines.]]> Wed 27 Nov 2019 12:59:39 AEST ]]> Providing social support to cancer patients: A look at alternative methods Wed 27 May 2015 13:45:35 AEST ]]> Testing the psychometric properties of the Patient Reported Outcomes: Cancer (PRO-C) instrument Wed 25 Sep 2019 14:44:41 AEST ]]> Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach Wed 20 Jun 2018 13:56:48 AEST ]]> The D-Health Trial: A randomized trial of vitamin D for prevention of mortality and cancer Wed 20 Jun 2018 12:46:48 AEST ]]> A systematic review of inequalities in psychosocial outcomes for women with breast cancer according to residential location and Indigenous status in Australia Wed 19 Apr 2017 11:34:33 AEST ]]> Clinical outcomes of vitamin D deficiency and supplementation in cancer patients Wed 06 May 2015 15:47:38 AEST ]]> Suppression of Sertoli cell tumour development during the first wave of spermatogenesis in inhibin α-deficient mice Wed 01 Nov 2017 12:28:53 AEST ]]> Community perceptions of bowel cancer: a survey of Queenslanders Tue 27 Aug 2019 15:45:47 AEST ]]> Cancer survivorship: does one size fit all? Tue 23 Oct 2018 15:52:02 AEST ]]> Screening for Psychosocial Distress: A National Survey of Oncology Social Workers Tue 21 Apr 2015 10:16:37 AEST ]]> The Amphimedon queenslandica genome and the evolution of animal complexity Tue 16 Oct 2018 12:41:08 AEST ]]> The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers 2 cm in diameter), are comparable with existing nonsurgical treatments. An active ingredient of E. peplus sap has been identified as ingenol mebutate (PEP005). This clinical study affirms community experience with E. peplus sap, and supports further clinical development of PEP005 for the treatment of BCC, SCC and IEC.]]> Tue 16 Oct 2018 12:24:07 AEST ]]> The value of Nature’s natural product library for the discovery of New Chemical Entities: The discovery of ingenol mebutate Tue 16 Oct 2018 12:15:52 AEST ]]> Population genetic analysis of a medicinally significant Australian rainforest tree, Fontainea picrosperma C.T. White (Euphorbiaceae): biogeographic patterns and implications for species domestication and plantation establishment Tue 16 Oct 2018 11:53:55 AEST ]]> Copy number alteration of neuropeptides and receptors in multiple cancers Tue 16 Oct 2018 11:07:48 AEST ]]> Clinical nurse specialist role in setting up a joint hepatocellular carcinoma clinic at a specialist liver unit Tue 15 Jan 2019 09:41:04 AEST ]]> Incidence and management of cancer pain in a large oncology unit Tue 15 Aug 2017 13:50:14 AEST ]]> Attitudes, knowledge and practice of crc screening among GPs in queensland Tue 15 Aug 2017 13:43:08 AEST ]]> Health-related quality of life and life satisfaction in colorectal cancer survivors: trajectories of adjustment Tue 12 Sep 2017 13:43:55 AEST ]]> Insider Research with Family Members Who Have a Member Living with Rare Cancer Tue 10 Sep 2019 17:04:54 AEST ]]> The benefits of Narrative research methods for nurses understanding cancer Thu 11 Feb 2016 08:31:49 AEST ]]> Benefits and Barriers of Cancer Practitioners Discussing Physical Activity with their Cancer Patients Thu 10 May 2018 12:41:48 AEST ]]> Distress Screening: Experiences of Oncology Social Workers Thu 06 Jul 2017 10:32:18 AEST ]]> Investigating How Bowel Cancer Survivors Discuss Exercise and Physical Activity Within Web-Based Discussion Forums: Qualitative Analysis Thu 02 Jan 2020 14:24:44 AEST ]]> Serum vitamin D decreases during chemotherapy: an Australian prospective cohort study Mon 22 Oct 2018 11:19:29 AEST ]]> Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases Mon 11 Sep 2017 12:12:11 AEST ]]> A Holistic Model of Care to Support Those Living with and beyond Cancer Mon 03 Jun 2019 12:03:43 AEST ]]> Floral and reproductive biology of the medicinally significant rainforest tree, Fontainea picrosperma (Euphorbiaceae) Fri 25 Jan 2019 09:36:25 AEST ]]> Critical Illness - A lived reality for patients and their families Fri 21 Jul 2017 12:39:00 AEST ]]> Web-Delivered Cognitive Behavioral Therapy for Distressed Cancer Patients: Randomized Controlled Trial Fri 20 Apr 2018 14:53:55 AEST ]]> Oncology social work practice in the care of breast and ovarian cancer survivors Fri 17 Jun 2016 16:42:54 AEST ]]> Working toward an understanding of the impact of hereditary cancers Fri 14 Aug 2015 13:40:43 AEST ]]> Narrative research methods with vulnerable people: sharing insights Fri 10 Jan 2020 10:05:16 AEST ]]> Strategies to improve the frequency and coverage of skin self examination conducted in small communities Fri 07 Nov 2014 14:23:27 AEST ]]> Evaluation of a Three-Year School-Based Intervention to Increase Adolescent Sun Protection Fri 07 Nov 2014 14:11:20 AEST ]]> Silent travellers on uncertain journeys: A phenomenological exploration of family members’ experiences of early stage rare cancer Fri 07 Nov 2014 13:34:27 AEST ]]> Cancer control activities in Australian public hospitals Fri 07 Nov 2014 13:00:18 AEST ]]> Insider research with families who have a member living with rare cancer Fri 07 Nov 2014 12:55:02 AEST ]]> Cancer Prevention Fri 07 Nov 2014 11:25:11 AEST ]]>